☰

Liqin Du, Ph.D. - Publications

Affiliations: 
2004 University of Kentucky, Lexington, KY 
Area:
Nutrition, Biochemistry
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Vernaza A, Cardus DF, Smith JL, Partridge V, Baker AL, Lewis EG, Zhang A, Zhao Z, Du L. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. Journal of Cancer. 15: 1153-1168. PMID 38356706 DOI: 10.7150/jca.89660  0.307
2023 Mesa-Diaz N, Smith MT, Cardus DF, Du L. Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells. Molecules (Basel, Switzerland). 28. PMID 37687123 DOI: 10.3390/molecules28176295  0.336
2020 Zhao Z, Shelton SD, Oviedo A, Baker AL, Bryant CP, Omidvarnia S, Du L. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. Journal of Experimental & Clinical Cancer Research : Cr. 39: 41. PMID 32087738 DOI: 10.1186/S13046-020-1531-2  0.452
2020 Baker AL, Zhao Z, Du L. Investigation of the Oncogenic Role of the Cell Cycle Regulator SAPCD2 in Pediatric Neuroblastoma The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09263  0.314
2019 Kosti A, Du L, Shivram H, Qiao M, Burns S, Garcia JG, Pertsemlidis A, Iyer VR, Kokovay E, Penalva LOF. ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state. Molecular Cancer Research : McR. PMID 31624087 DOI: 10.1158/1541-7786.Mcr-19-0187  0.452
2018 Zhao Z, Partridge V, Sousares M, Shelton SD, Holland CL, Pertsemlidis A, Du L. microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi. Plos One. 13: e0208777. PMID 30550571 DOI: 10.1371/Journal.Pone.0208777  0.448
2018 Du L, Zhao Z, Suraokar M, Shelton SS, Ma X, Hsiao TH, Minna JD, Wistuba I, Pertsemlidis A. LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget. 9: 29601-29618. PMID 30038707 DOI: 10.18632/Oncotarget.25642  0.406
2018 Yu X, Zhang Y, Cavazos D, Ma X, Zhao Z, Du L, Pertsemlidis A. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer. Cell Death & Disease. 9: 193. PMID 29416000 DOI: 10.1038/S41419-017-0219-9  0.479
2017 Sousares M, Partridge V, Weigum S, Du L. MicroRNAs in neuroblastoma differentiation and differentiation therapy Advances in Modern Oncology Research. 3. DOI: 10.18282/AMOR.V3.I5.233  0.31
2017 Yu X, Ma X, Zhang Y, Zhao Z, Du L, Pertsemlidis A. Abstract 5444: Therapeutic potential of miR-195 in non-small cell lung cancer Cancer Research. 77: 5444-5444. DOI: 10.1158/1538-7445.Am2017-5444  0.456
2016 Zhao Z, Ma X, Shelton SD, Sung DC, Li M, Hernandez D, Zhang M, Losiewiz MD, Chen Y, Pertsemlidis A, Yu X, Liu Y, Du L. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells. Oncotarget. PMID 27764804 DOI: 10.18632/Oncotarget.12676  0.46
2016 Ma X, Yu X, Patolia H, Zhao Z, Du L, Pertsemlidis A. Abstract 1940: Non-coding RNA regulation of eribulin response in neuroblastoma Cancer Research. 76: 1940-1940. DOI: 10.1158/1538-7445.Am2016-1940  0.382
2016 Yu X, Zhao Z, Ma X, Du L, Pertsemlidis A. Abstract 1063: miR-195 represses the tumorigenesis of non-small cell lung cancer and synergizes with microtubule targeting agents Cancer Research. 76: 1063-1063. DOI: 10.1158/1538-7445.Am2016-1063  0.448
2015 Zhao Z, Ma X, Sung D, Li M, Kosti A, Lin G, Chen Y, Pertsemlidis A, Hsiao TH, Du L. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. Rna Biology. 12: 538-54. PMID 25760387 DOI: 10.1080/15476286.2015.1023495  0.425
2015 Borkowski R, Du L, Zhao Z, McMillan E, Kosti A, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, White MA, Pertsemlidis A. Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Research. 75: 666-75. PMID 25519225 DOI: 10.1158/0008-5472.Can-14-1329  0.492
2014 Zhao Z, Ma X, Hsiao TH, Lin G, Kosti A, Yu X, Suresh U, Chen Y, Tomlinson GE, Pertsemlidis A, Du L. A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation. Oncotarget. 5: 2499-512. PMID 24811707 DOI: 10.18632/Oncotarget.1703  0.425
2014 Du L, Zhao Z, Ma X, Hsiao TH, Chen Y, Young E, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene. 33: 4307-15. PMID 24037530 DOI: 10.1038/Onc.2013.381  0.495
2014 Zhao Z, Ma X, Yu X, Hsiao T, Chen Y, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A, Du L. Abstract 466: LMO1 is a novel oncogene in neuroendocrine lung cancer Cancer Research. 74: 466-466. DOI: 10.1158/1538-7445.Am2014-466  0.391
2014 Yu X, Zhao Z, Ma X, Du L, Pertsemlidis A. Abstract 3545: A high-throughput screen identifies microRNAs regulating lung cancer cell survival and response to paclitaxel Cancer Research. 74: 3545-3545. DOI: 10.1158/1538-7445.Am2014-3545  0.495
2013 Du L, Borkowski R, Zhao Z, Ma X, Yu X, Xie XJ, Pertsemlidis A. A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel. Rna Biology. 10: 1700-13. PMID 24157646 DOI: 10.4161/Rna.26541  0.447
2013 Du L, Zhao Z, Young E, Ma X, Wistuba I, Pertsemlidis A. Abstract 3096: miR-93-directed down-regulation of Dab2 defines a novel oncogenic pathway in lung cancer. Cancer Research. 73: 3096-3096. DOI: 10.1158/1538-7445.Am2013-3096  0.495
2013 DeSevo C, Du L, Behrens C, Wistuba I, Minna J, Pertsemlidis A. Abstract 3049: miR-10a regulates PI3K signaling and paclitaxel response in NSCLC. Cancer Research. 73: 3049-3049. DOI: 10.1158/1538-7445.Am2013-3049  0.445
2012 Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opinion On Biological Therapy. 12: 1221-39. PMID 22731874 DOI: 10.1517/14712598.2012.697149  0.423
2012 Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, Pertsemlidis A. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. Plos One. 7: e39167. PMID 22723956 DOI: 10.1371/Journal.Pone.0039167  0.48
2012 Du L, DeSevo C, Robert B, Michael B, Gazdar AF, Minna JD, Pertsemlidis A. Abstract B7: microRNA regulation of cell viability and drug sensitivity in lung cancer Cancer Research. 72: B7-B7. DOI: 10.1158/1538-7445.Nonrna12-B7  0.496
2012 DeSevo C, Du L, Behrens C, Wistuba II, Minna J, Pertsemlidis A. Abstract A2: miR-10a regulation of PIK3CA and response to taxol in non small cell lung cancer Cancer Research. 72: A2-A2. DOI: 10.1158/1538-7445.NONRNA12-A2  0.302
2012 Du L, DeSevo C, Borkowski R, Baker M, Wistuba I, Minna J, Pertsemlidis A. Abstract 140: microRNA regulation of cell viability and drug response in cancer Cancer Research. 72: 140-140. DOI: 10.1158/1538-7445.Am2012-140  0.482
2011 Nikolic D, Calderon L, Du L, Post SR. SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. Bmc Immunology. 12: 37. PMID 21736734 DOI: 10.1186/1471-2172-12-37  0.604
2011 Du L, Pertsemlidis A. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. Journal of Molecular Cell Biology. 3: 176-80. PMID 21278200 DOI: 10.1093/Jmcb/Mjq058  0.328
2011 Du L, Subauste MC, Baker M, DeSevo C, Borkowski R, Zhong S, Schageman JJ, Greer R, Yang C, Girard L, Gazdar AF, Wistuba II, Minna JD, Pertsemlidis A. Abstract 4709: miR-337-3p and its targets STAT3 and RAP1A modulate paclitaxel sensitivity in non-small cell lung cancers (NSCLCs) Cellular and Molecular Biology. 71: 4709-4709. DOI: 10.1158/1538-7445.Am2011-4709  0.455
2011 Borkowski R, Du L, Minna JD, Gazdar AF, Pertsemlidis A. Abstract 3958: A miRNA inhibitor screen for synthetic lethal interactions in KRAS-driven NSCLC Cancer Research. 71: 3958-3958. DOI: 10.1158/1538-7445.Am2011-3958  0.397
2010 Du L, Schageman JJ, Irnov, Girard L, Hammond SM, Minna JD, Gazdar AF, Pertsemlidis A. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. Journal of Experimental & Clinical Cancer Research : Cr. 29: 75. PMID 20624269 DOI: 10.1186/1756-9966-29-75  0.421
2010 Du L, Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Reviews. 29: 109-22. PMID 20130964 DOI: 10.1007/S10555-010-9204-9  0.384
2010 Subauste MC, Sansom OJ, Porecha N, Raich N, Du L, Maher JF. Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells. Molecular Carcinogenesis. 49: 105-13. PMID 19908242 DOI: 10.1002/Mc.20594  0.361
2010 Du L, Pertsemlidis A. Erratum to: microRNAs and lung cancer: tumors and 22-mers Cancer and Metastasis Reviews. 29: 801-802. DOI: 10.1007/S10555-010-9230-7  0.371
2009 Subauste MC, Ventura-Holman T, Du L, Subauste JS, Chan SL, Yu VC, Maher JF. RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells. Cancer Biology & Therapy. 8: 2297-305. PMID 19855191 DOI: 10.4161/Cbt.8.23.10262  0.369
2009 Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes & Development. 23: 2140-51. PMID 19759262 DOI: 10.1101/Gad.1820209  0.434
2009 Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Molecular Cancer Research : McR. 7: 1234-43. PMID 19671678 DOI: 10.1158/1541-7786.Mcr-08-0507  0.5
2004 Du L, Post SR. Macrophage colony-stimulating factor differentially regulates low density lipoprotein and transferrin receptors. Journal of Lipid Research. 45: 1733-40. PMID 15210846 DOI: 10.1194/Jlr.M400140-Jlr200  0.586
Show low-probability matches.